HomeComparePKI vs BLK

PKI vs BLK: Dividend Comparison 2026

PKI yields 0.24% · BLK yields 2.29%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLK wins by $82.4K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
BLK
BLK
● Live price
2.29%
Share price
$934.06
Annual div
$21.36
5Y div CAGR
46.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.1K
Annual income
$35,513.89
Full BLK calculator →

Portfolio growth — PKI vs BLK

📍 BLK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKIBLK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + BLK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
BLK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
BLK
Annual income on $10K today (after 15% tax)
$194.38/yr
After 10yr DRIP, annual income (after tax)
$30,186.81/yr
At 15% tax rate, BLK beats the other by $30,186.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + BLK for your $10,000?

PKI: 50%BLK: 50%
100% BLK50/50100% PKI
Portfolio after 10yr
$60.9K
Annual income
$17,756.96/yr
Blended yield
29.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BLK right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
BLK
Analyst Ratings
24
Buy
9
Hold
Consensus: Buy
Price Target
$1,348.56
+44.4% upside vs current
Range: $1,255.00 — $1,514.00
Altman Z
1.5
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
BLK buys
0
No recent congressional trades found for PKI or BLK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKIBLK
Forward yield0.24%2.29%
Annual dividend / share$0.28$21.36
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%46.6%
Portfolio after 10y$19.7K$102.1K
Annual income after 10y$0.02$35,513.89
Total dividends collected$24.00$75.3K
Payment frequencyquarterlyquarterly
SectorStockFinancials
Analyst consensusHoldBuy
Analyst price target$166.57$1,348.56

Year-by-year: PKI vs BLK ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrBLK PortfolioBLK Income/yrGap
1← crossover$10,712$12.15$11,035$335.24$323.00BLK
2$11,468$6.08$12,315$506.87$847.00BLK
3$12,274$3.04$13,952$774.96$1.7KBLK
4$13,135$1.52$16,131$1,202.91$3.0KBLK
5$14,055$0.76$19,166$1,905.57$5.1KBLK
6$15,039$0.38$23,609$3,101.98$8.6KBLK
7$16,092$0.19$30,497$5,235.36$14.4KBLK
8$17,218$0.10$41,898$9,265.63$24.7KBLK
9$18,424$0.05$62,271$17,440.30$43.8KBLK
10$19,713$0.02$102,144$35,513.89$82.4KBLK

PKI vs BLK: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

BLKFinancials

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks. It also provides global risk management and advisory services. The firm manages separate client-focused equity, fixed income, and balanced portfolios. It also launches and manages open-end and closed-end mutual funds, offshore funds, unit trusts, and alternative investment vehicles including structured funds. The firm launches equity, fixed income, balanced, and real estate mutual funds. It also launches equity, fixed income, balanced, currency, commodity, and multi-asset exchange traded funds. The firm also launches and manages hedge funds. It invests in the public equity, fixed income, real estate, currency, commodity, and alternative markets across the globe. The firm primarily invests in growth and value stocks of small-cap, mid-cap, SMID-cap, large-cap, and multi-cap companies. It also invests in dividend-paying equity securities. The firm invests in investment grade municipal securities, government securities including securities issued or guaranteed by a government or a government agency or instrumentality, corporate bonds, and asset-backed and mortgage-backed securities. It employs fundamental and quantitative analysis with a focus on bottom-up and top-down approach to make its investments. The firm employs liquidity, asset allocation, balanced, real estate, and alternative strategies to make its investments. In real estate sector, it seeks to invest in Poland and Germany. The firm benchmarks the performance of its portfolios against various S&P, Russell, Barclays, MSCI, Citigroup, and Merrill Lynch indices. BlackRock, Inc. was founded in 1988 and is based in New York City with additional offices in Boston, Massachusetts; London, United Kingdom; Gurgaon, India; Hong Kong; Greenwich, Connecticut; Princeton, New Jersey; Edinburgh, United Kingdom; Sydney, Australia; Taipei, Taiwan; Singapore; Sao Paulo, Brazil; Philadelphia, Pennsylvania; Washington, District of Columbia; Toronto, Canada; Wilmington, Delaware; and San Francisco, California.

Full BLK Calculator →
📬

Get this PKI vs BLK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.